Aberrant lactate dehydrogenase A signaling contributes metabolic signatures in pancreatic cancer

BACKGROUND: Pancreatic cancer (PC) has the lowest 5-year survival rate; therefore, new early screening methods and therapeutic targets are still urgently required. Emerging technologies such as metabolomic-based liquid biopsy may contribute to the field. We found aberrant lactate dehydrogenase A (LD...

Full description

Saved in:
Bibliographic Details
Published in:Ann Transl Med
Main Authors: Jiang, Wenna, Qiao, Lu, Zuo, Duo, Qin, Di, Xiao, Jiawei, An, Haohua, Wang, Yanhui, Zhang, Xinwei, Jin, Yu, Ren, Li
Format: Artigo
Language:Inglês
Published: AME Publishing Company 2021
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7944301/
https://ncbi.nlm.nih.gov/pubmed/33708985
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-21-295
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items